Clinical Study of 68Ga-LNC1007 Injection PET/CT

NCT06463782 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

8

Enrollment

INDUSTRY

Sponsor class

Conditions

Healthy Volunteers
Cancer Patients

Interventions

DRUG: 68Ga-LNC1007 Injection

Sponsor

Yantai LNC Biotechnology Singapore PTE. LTD.